Source: Liontown Resources
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Albemarle Corporation withdraws its proposal to acquire Liontown Resources (ASX:LTR)
  • The previous deal was to acquire all outstanding shares for $3.00 each via a scheme of arrangement
  • Albemarle’s decision was based on the increasing complexities associated the transaction
  • Liontown’s focus now turns to delivering the Kathleen Valley project by mid-2024
  • LTR shares last traded at $2.79 before entering a halt

Liontown Resources (ASX:LTR) had previously received a non-binding proposal from Albemarle Corporation to acquire all outstanding shares for $3.00 each via a scheme of arrangement.

However, Albemarle has now decided not to proceed with this proposed acquisition.

Albemarle’s decision to withdraw its proposal was based on the increasing complexities associated with executing the transaction.

Despite this, Albemarle expressed a positive view of Liontown’s flagship Kathleen Valley project and its management.

Liontown remains unwavering in its commitment to its strategic plan and is confident in its ability to succeed independently.

The focus of Liontown’s Board of Directors and leadership team is on bringing the Kathleen Valley lithium project into production.

“We acknowledge Albemarle’s decision. They were constructive and respectful throughout the diligence process,” LTR Managing Director and CEO Tony Ottaviano said.

Liontown Resources is currently in a trading halt but last traded at $2.79.


LTR by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…